Sandusky Wellness Ctr., LLC v. MedTox Scientific, Inc.
Decision Date | 03 May 2016 |
Docket Number | No. 15–1317.,15–1317. |
Citation | 821 F.3d 992 |
Parties | SANDUSKY WELLNESS CENTER, LLC, an Ohio limited liability company, individually and as the representative of a class of similarly situated persons, Plaintiff–Appellant. v. MEDTOX SCIENTIFIC, INC.; Medtox Laboratories, Inc.; John Does 1–10, Defendants–Appellees. |
Court | U.S. Court of Appeals — Eighth Circuit |
Glenn L. Hara, argued, Rolling Meadows, IL (Brant D. Penney, Saint Paul, MN, on the brief), for Appellant.
Robert Ira Steiner, argued, New York, N.Y. (Geoffrey W. Castello, New York, N.Y., Lewis Albert Remele, Jr., Jeffrey Mulder, Jessica Lee Prom Klander, Minneapolis, MN, on the brief), for Appellee.
Before SMITH, BYE, and BENTON, Circuit Judges.1
Sandusky Wellness Center, LLC, received an unsolicited fax from MedTox Laboratories, Inc. Sandusky brought a class action under the Telephone Consumer Protection Act (TCPA). The district court denied class certification, finding the class not ascertainable. Having jurisdiction under 28 U.S.C. § 1291, this court reverses and remands.
In February 2012, MedTox, a toxicology lab, decided to contact pediatricians, family practitioners, health departments, and child-focused organizations about its lead-testing capabilities. Using a directory from a health insurance company, MedTox created a contact list of 4,210 fax numbers. Between February 18 and 26, MedTox successfully transmitted a single-page fax to 3,256 numbers, including Sandusky's number.
Sandusky is a chiropractic center owned by Dr. Gregg D. Winnestaffer, a chiropractor. Sandusky's name is not on the contact list. Rather, Dr. Bruce Montgomery—who worked one day a week at the center—is on the contact list. Dr. Montgomery, a family practitioner, occasionally required lead-testing for patients. Dr. Montgomery did give Sandusky's fax number to the health insurance company, which gave it to MedTox. MedTox's fax to Sandusky's number was not addressed to anyone and had no opt-out notice. Dr. Winnestaffer forwarded the fax to Sandusky's counsel, who filed this case.
In April 2014, Sandusky moved to certify as a TCPA class: “All persons who (1) on or after four years prior to the filing of this action, (2) were sent telephone facsimile messages regarding lead testing services by or on behalf of Medtox, and (3) which did not display a proper opt out notice.”
The district court denied class certification, holding the class was “not ascertainable, because it does not objectively establish who is included in the class.” Both parties moved for summary judgment. Sandusky requested a $500 judgment and an injunction prohibiting MedTox from sending unsolicited faxes to Sandusky. MedTox argued that a settlement offer—$3,500 and a promise not to send more faxes—mooted Sandusky's claim. The district court granted summary judgment to MedTox, holding its offer mooted Sandusky's entire demand. Sandusky appeals the denial of class certification, the order dismissing its case as moot, and the final judgment for MedTox.
This court reviews a denial of class certification for abuse of discretion. Avritt v. Reliastar Life Ins. Co., 615 F.3d 1023, 1029 (8th Cir.2010). A district court abuses its discretion if, as relevant here, it commits an error of law. In re Zurn Pex Plumbing Prods. Liab. Litig., 644 F.3d 604, 616 (8th Cir.2011).
Federal Rule of Civil Procedure 23(a) Avritt, 615 F.3d at 1029. The district court did not discuss the four requirements at length because: “Before considering the explicit requirements set forth in Rule 23 ... the court must be satisfied that the proposed class is ascertainable.” Sandusky Wellness Center LLC v. Medtox Scientific, Inc., 2014 WL 3846037, *3 (D.Minn. Aug. 5, 2014).
Most of the other circuit courts of appeals have “recognized that Rule 23 contains an implicit threshold requirement that the members of a proposed class be ‘readily identifiable’ .... an ‘ascertainability’ requirement.” EQT Prod. Co. v. Adair, 764 F.3d 347, 358 (4th Cir.2014). See, e.g., In re Nexium Antitrust Litig., 777 F.3d 9, 19 (1st Cir.2015) ( ); Brecher v. Republic of Argentina, 806 F.3d 22, 24 (2d Cir.2015) ( ); Marcus v. BMW of North America, LLC, 687 F.3d 583, 592–93 (3d Cir.2012) ( ); Union Asset Management Holding A.G. v. Dell, Inc., 669 F.3d 632, 639 (5th Cir.2012) (); Rikos v. Procter & Gamble Co., 799 F.3d 497, 525 (6th Cir.2015) (discussing “the ascertainability inquiry”); Mullins v. Direct Digital, LLC, 795 F.3d 654, 659 (7th Cir.2015) ( ); Berger v. Home Depot USA, Inc., 741 F.3d 1061, 1071 n. 3 (9th Cir.2014) ( ); Little v. T–Mobile USA, Inc., 691 F.3d 1302, 1304 (11th Cir.2012) ().
The circuits diverge on the meaning of ascertainability. The Third Circuit has a heightened test for ascertainability, which the Seventh Circuit expressly rejects. The Third Circuit states that a “plaintiff seeking certification of a Rule 23(b)(3) class must prove by a preponderance of the evidence that the class is ascertainable.” Byrd v. Aaron's Inc., 784 F.3d 154, 163 (3d Cir.2015). “The ascertainability inquiry is two-fold, requiring a plaintiff to show that: (1) the class is ‘defined with reference to objective criteria’; and (2) there is ‘a reliable and administratively feasible mechanism for determining whether putative class members fall within the class definition.’ ” Id. ( ). See also Brecher, 806 F.3d at 24 ( ); Karhu v. Vital Pharm., Inc., 621 Fed.Appx. 945, 947 (11th Cir.2015) ().
Rejecting the Third Circuit's heightened standard, the Seventh Circuit says: Mullins, 795 F.3d at 658. According to the Seventh Circuit, a heightened ascertainability requirement “gives one factor in the balance absolute priority, with the effect of barring class actions where class treatment is often most needed: in cases involving relatively low-cost goods or services, where consumers are unlikely to have documentary proof of purchase.” Id. See also id. at 672 (, )criticizing Carrera v. Bayer Corp., 727 F.3d 300, 304 (3d Cir.2013) ( ). Affirming the class certification in Mullins, the Seventh Circuit held the class was “not vague,” “not based on subjective criteria,” and did identify “a particular group of individuals ... harmed in a particular way ... during a specific period in particular areas.” Id. at 660–61. The court so held even assuming there were “no records for a large number of retail customers” and that consumers were “unlikely to have kept their receipts.” Id. at 661. See also Rikos, 799 F.3d at 525 ( ).
This court, unlike most other courts of appeals, has not outlined a requirement of ascertainability. “It is elementary that in order to maintain a class action, the class sought to be represented must be adequately defined and clearly ascertainable.” Ihrke v. N. States Power Co., 459 F.2d 566, 573 n. 3 (8th Cir.) ( ), vacated due to mootness, 409 U.S. 815, 93 S.Ct. 66, 34 L.Ed.2d 72 (1972). Since Ihrke, this court has not addressed ascertainability as a separate, preliminary requirement. Rather, this court adheres to a rigorous analysis of the Rule 23 requirements, which includes that a class “must be adequately defined and clearly ascertainable.”
Sandusky's class definition includes: “All persons who (1) on or after four years prior to the filing of this action, (2) were sent...
To continue reading
Request your trial-
Sabata v. Neb. Dep't of Corr. Servs.
...central to the validity of each one of the claims in one stroke.'" Postawko, 910 F.3d at 1038 (quoting Sandusky Wellness Ctr., LLC v. Medtox Sci., Inc., 821 F.3d 992, 998 (8th Cir. 2016)). "The mere presence of one or more common questions is not enough; rather, the district court must exam......
-
In re EpiPen Marketing, Sales Practices & Antitrust Litig.
...but rejecting the "heightened ascertainability requirement" imposed by the Third Circuit); see also Sandusky Wellness Ctr., LLC v. Medtox Sci., Inc., 821 F.3d 992, 996 (8th Cir. 2016) (discussing criticism of the Third Circuit's standard and refusing to install "a separate, preliminary [asc......
-
In re McCormick & Co., Inc., Pepper Prods. Mktg. & Sales Practices Litig.
...the D.C. Circuit) have held that "ascertainability" is an implied requirement under Rule 23. See Sandusky Wellness Ctr., LLC v. Medtox Scientific, Inc. , 821 F.3d 992, 995 (8th Cir. 2016) (citing cases from First, Second, Third, Fourth, Fifth, Sixth, Seventh, Ninth and Eleventh Circuits). H......
-
Skaar v. Wilkie
... ... scientific or medical evidence linking the disease to ... Sunshine Mobile Homes, ... Inc. , 280 F.Supp. 805, 826 (W.D. La. 2003). The ... See, e.g. , Hinman v ... M&M Rental Ctr., Inc. , 545 F.Supp.2d 802, 806 (N.D ... Fed.Appx. 44, 47 (2d Cir. 2017); Sandusky Wellness Ctr., ... LLC v. Medtox Sci., Inc ... ...
-
The End of Low-value Consumer Class Action Lawsuits?: the Federal Circuit Split on the Ascertainability Requirement for Class Certification
...Wellness Center, LLC v. Medtox Science, Inc. is an example of the lower standard's application of ascertainability of class members. 821 F.3d 992 (8th Cir. 2016). Instead of making a separate ascertainability requirement, like those circuits that have adopted the higher standard of ascertai......
-
Class Actions
...250, 267 (2d Cir. 2017); Rikos v. P&G, 799 F.3d 497, 525 (6th Cir. 2015); Mullins, 795 F.3d at 662; Sandusky Wellness Ctr. v. MedTox Sci., 821 F.3d 992, 995-96 (8th Cir. 2016); Briseno v. ConAgra Foods, 844 F.3d 1121, 1123 (9th Cir. 2017).21. In re Nexium Antitrust Litig., 777 F.3d 9, 19 (1......
-
Chapter 12
...threshold requirement that the members of the class be readily identifiable" (quoting Sandusky Wellness Ctr., LLC v. Medtox Sci., Inc., 821 F.3d 992 (8th Cir. 2016)). The doctrine, sometimes called the "ascertainability requirement," means that to be certified, the class must be "sufficient......
-
The Critical Importance—or Complete Irrelevance—of Class Ascertainability in the Class Certification Decision, and the Unacceptable Circuit Split
...purchases.109 Granting class certification was appropriate.H. The Eighth Circuit—Sandusky Wellness Ctr., LLC, v. MedTox Sci., Inc., 821 F.3d 992 (8th Cir. 2016) In Sandusky Wellness Center, LLC, v. MedTox Scientific, Inc.,110 plaintiff sued MedTox Scientific under the Telephone Consumer Pro......